Federal Register Notice: FDA is reopening to 12/6 the comment period for the 4/2 Federal Register notice related to a 4/27 public hearing on the electronic distribution of FDA-approved prescribing information currently contained in the package insert for prescription drug and biological products. To view this notice, click here.
